{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:21Z","timestamp":1792787301566,"version":"4.5.0"},"reference-count":33,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"unspecified","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Istanbul University Scientific Research Projects Coordination Unit","award":["TTU-2021-38289"],"award-info":[{"award-number":["TTU-2021-38289"]}],"id":[{"id":"https:\/\/ror.org\/03a5qrr21","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,7,30]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>CD163 is a macrophage-associated scavenger receptor shed during inflammatory activation, resulting in measurable soluble CD163 in serum (s) and urine (u). Elevated levels have been reported in inflammatory and immune-mediated conditions, including lupus nephritis (LN). This study aimed to investigate the relationship between soluble CD163 levels and intrarenal CD163 expression, evaluating their association with disease activity and treatment response in LN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty-five patients with systemic lupus erythematosus (SLE) were included (20 active LN, 10 inactive LN, 15 active extra-renal SLE), together with 20 matched healthy controls. Serum and urine samples were collected at baseline alongside renal biopsy in active LN; 6-month follow-up samples were available for 12 active LN patients. CD163 was measured by ELISA; urinary CD163 was normalised to spot urine creatinine. Renal biopsies from 20 active LN patients were evaluated for CD163+ macrophage density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>uCD163 was higher in active LN (a renal Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) flare (UPCR \u22650.5\u2009g\/g) with biopsy-proven active lesions) than in inactive LN and active extra-renal SLE (both p&lt;0.001), discriminating active from inactive LN (area under the curve (AUC) 0.97) and from extra-renal SLE (AUC 0.89). uCD163 correlated with the National Institutes of Health activity and chronicity indices activity index (\u03c1=0.55, p=0.016) and with glomerular CD163+ macrophage density (the number of CD163+ macrophages per glomerulus quantified by immunohistochemistry; \u03c1=0.65, p=0.006), but not with chronicity. Glomerular CD163+ macrophage density also correlated with sCD163 (\u03c1=0.60, p=0.01) and uCD163 (\u03c1=0.63, p=0.009). After 6-month induction, uCD163 fell from 7.41 to 1.55\u2009ng\/mg (p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>uCD163 distinguishes active LN from inactive renal and extra-renal disease and tracks treatment response. The association with intrarenal CD163+ macrophages supports its biological relevance as a non-invasive marker of renal inflammation, complementary to histopathology when repeat biopsy is not feasible. These findings support uCD163 as a candidate non-invasive tool for identifying active LN and monitoring treatment response in SLE, warranting validation in larger prospective cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2026-002166","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:30:20Z","timestamp":1786361420000},"page":"e002166","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["CD163: a potential biomarker for lupus nephritis activity"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-5928","authenticated-orcid":false,"given":"Erdem","family":"G\u00fcrel","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"\u00c7inar","sequence":"additional","affiliation":[{"name":"Department of Immunology, Istanbul University Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"H\u00fcrdogan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"\u00d6zl\u00fck","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Keme\u00e7","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Uluda\u011f","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Varelci","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0362-8154","authenticated-orcid":false,"given":"Safak","family":"Mirio\u011flu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Yal\u00e7inkaya","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"G\u00fcl","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-5583","authenticated-orcid":false,"given":"Murat","family":"Inan\u00e7","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5659-3955","authenticated-orcid":false,"given":"Bahar","family":"Artim-Esen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026092908102225000_13.2.e002166.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071297"},{"key":"2026092908102225000_13.2.e002166.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.017"},{"key":"2026092908102225000_13.2.e002166.3","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/638413","article-title":"Biomarkers for lupus nephritis: a critical appraisal","volume":"2010","author":"Mok","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"2026092908102225000_13.2.e002166.4","first-page":"1563","article-title":"Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure","volume":"33","author":"Faurschou","year":"2006","journal-title":"J Rheumatol"},{"key":"2026092908102225000_13.2.e002166.5","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1576"},{"key":"2026092908102225000_13.2.e002166.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(01)00218-4"},{"key":"2026092908102225000_13.2.e002166.7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409629200"},{"key":"2026092908102225000_13.2.e002166.8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.217"},{"key":"2026092908102225000_13.2.e002166.9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.prp.2017.04.011","article-title":"Significance of M2 macrophages in glomerulonephritis with crescents","volume":"213","author":"Li","year":"2017","journal-title":"Pathology - Research and Practice"},{"key":"2026092908102225000_13.2.e002166.10","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0294"},{"key":"2026092908102225000_13.2.e002166.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1568-1","article-title":"Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons","volume":"20","author":"Kishimoto","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2026092908102225000_13.2.e002166.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2009.05.003"},{"key":"2026092908102225000_13.2.e002166.13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10067-020-05343-6","article-title":"Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis","volume":"40","author":"Gupta","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026092908102225000_13.2.e002166.14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019121285"},{"key":"2026092908102225000_13.2.e002166.15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0961203320932663","article-title":"Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity","volume":"29","author":"Allam","year":"2020","journal-title":"Lupus"},{"key":"2026092908102225000_13.2.e002166.16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/BOR.0000000000000862","article-title":"Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights","volume":"34","author":"Lindblom","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"2026092908102225000_13.2.e002166.17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/rheumatology\/keac465","article-title":"Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis","volume":"62","author":"Inthavong","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908102225000_13.2.e002166.18","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026092908102225000_13.2.e002166.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2026092908102225000_13.2.e002166.20","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026092908102225000_13.2.e002166.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2026092908102225000_13.2.e002166.22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002118"},{"key":"2026092908102225000_13.2.e002166.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00109-0"},{"key":"2026092908102225000_13.2.e002166.24","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026092908102225000_13.2.e002166.25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172569","article-title":"Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis","volume":"9","author":"Fava","year":"2024","journal-title":"JCI Insight"},{"key":"2026092908102225000_13.2.e002166.26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/art.42023","article-title":"Urine Proteomics and Renal Single-Cell Transcriptomics Implicate Interleukin-16 in Lupus Nephritis","volume":"74","author":"Fava","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026092908102225000_13.2.e002166.27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw214"},{"key":"2026092908102225000_13.2.e002166.28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0961203319860201","article-title":"Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus","volume":"28","author":"Nishino","year":"2019","journal-title":"Lupus"},{"key":"2026092908102225000_13.2.e002166.29","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1093\/rheumatology\/keaf446","article-title":"Urinary soluble CD163 is useful to predict lupus nephritis activity and to monitor standard-of-care therapy response","volume":"64","author":"Renaudineau","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908102225000_13.2.e002166.30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100244","article-title":"Urinary soluble CD163 is useful as \u201cliquid biopsy\u201d marker in lupus nephritis at both diagnosis and follow-up to predict impending flares","volume":"9","author":"Renaudineau","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"2026092908102225000_13.2.e002166.31","doi-asserted-by":"crossref","first-page":"3000605211049963","DOI":"10.1177\/03000605211049963","article-title":"Elevated soluble CD163 predicts renal function deterioration in lupus nephritis: a cohort study in Eastern China","volume":"49","author":"Yang","year":"2021","journal-title":"J Int Med Res"},{"key":"2026092908102225000_13.2.e002166.32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00671","article-title":"Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"2026092908102225000_13.2.e002166.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-0989-y","article-title":"CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis","volume":"18","author":"Olmes","year":"2016","journal-title":"Arthritis Res Ther"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-002166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:15:03Z","timestamp":1790694903000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,10]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/lupus-2026-002166"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-002166","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}